Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function

References

• SuissaSBarnesPJInhaled corticosteroids in COPD: the case againstEur Respir J2009341131619567599
   PubMed Web of Science ®Google Scholar
• PostmaDSCalverleyPInhaled corticosteroids in COPD: a case in favourEur Respir J2009341101219567598
   PubMed Web of Science ®Google Scholar
• CrimCCalverleyPMAndersonJAPneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study resultsEur Respir J200934364164719443528
   PubMed Web of Science ®Google Scholar
• WedzichaJACalverleyPMSeemungalTAThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
   PubMed Web of Science ®Google Scholar
• AnzuetoAFergusonGTFeldmanGEffect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomesCOPD20096532032919863361
   PubMedGoogle Scholar
• FergusonGTAnzuetoAFeiREmmettAKnobilKKalbergCEffect of fluticasone propionate/salmeterol (250/50 µg) or salmeterol (50 µg) on COPD exacerbationsRespir Med200810281099110818614347
   PubMed Web of Science ®Google Scholar
• JenkinsCRJonesPWCalverleyPMEfficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyRespir Res2009105919566934
   PubMed Web of Science ®Google Scholar
• HollisSJorupCLythgoeDMartenssonGRegnellPEckerwallGRisk of pneumonia with budesonide-containing treatments in COPD: an individual patient-level pooled analysis of interventional studiesInt J Chron Obstruct Pulmon Dis2017121071108428435240
   PubMed Web of Science ®Google Scholar
• JansonCLarssonKLisspersKHPneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS)BMJ2013346f330623719639
   PubMed Web of Science ®Google Scholar
• YangHHLaiCCWangYHSevere exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting β2 agonistInt J Chron Obstruct Pulmon Dis2017122477248528860742
   PubMed Web of Science ®Google Scholar
• WangCYLaiCCYangWCThe association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) studyInt J Chron Obstruct Pulmon Dis2016112775278327877031
   PubMed Web of Science ®Google Scholar
• SuissaSPatenaudeVLapiFErnstPInhaled corticosteroids in COPD and the risk of serious pneumoniaThorax201368111029103624130228
   PubMed Web of Science ®Google Scholar
• JansonCStratelisGMiller-LarssonAHarrisonTWLarssonKScientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPDInt J Chron Obstruct Pulmon Dis2017123055306429089754
   PubMed Web of Science ®Google Scholar
• RestrepoMIMortensenEMPughJAAnzuetoACOPD is associated with increased mortality in patients with community-acquired pneumoniaEur Respir J200628234635116611653
   PubMed Web of Science ®Google Scholar
• HolguinFFolchEReddSCManninoDMComorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001Chest200512842005201116236848
   PubMed Web of Science ®Google Scholar
• EkALarssonKSiljerudSPalmbergLFluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophagesAllergy199954769169910442524
   PubMed Web of Science ®Google Scholar
• DalbyCPolanowskiTLarssonTBorgströmLEdsbäckerSHarrisonTWThe bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trialRespir Res20091010419878590
   PubMed Web of Science ®Google Scholar
• EdsbäckerSWollmerPSelroosOBorgströmLOlssonBIngelfJDo airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids?Pulm Pharmacol Ther200821224725817950641
   PubMed Web of Science ®Google Scholar
• BarnesPJAlveolar macrophages as orchestrators of COPDCOPD200411597016997739
   PubMedGoogle Scholar
• BerensonCSGarlippMAGroveLJMaloneyJSethiSImpaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary diseaseJ Infect Dis2006194101375138417054066
   PubMed Web of Science ®Google Scholar
• TaylorAEFinney-HaywardTKQuintJKDefective macrophage phagocytosis of bacteria in COPDEur Respir J20103551039104719897561
   PubMed Web of Science ®Google Scholar
• ContoliMPaulettiARossiMRLong-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPDEur Respir J2017504170045128982774
   PubMed Web of Science ®Google Scholar
• AllportJRDonnellyLEKefalasPA possible role for mono (ADP-ribosyl) transferase in the signalling pathway mediating neutrophil chemotaxisBr J Clin Pharmacol1996421991068807150
   PubMed Web of Science ®Google Scholar
• AberdeinJDColeJBewleyMAMarriottHMDockrellDHAlveolar macrophages in pulmonary host defence: the unrecognized role of apoptosis as a mechanism of intracellular bacterial killingClin Exp Immunol2013174219320223841514
   PubMed Web of Science ®Google Scholar
• van der GoesAHoekstraKvan den BergTKDijkstraCDDexamethasone promotes phagocytosis and bacterial killing by human monocytes/macrophages in vitroJ Leukoc Biol200067680180710857852
   PubMed Web of Science ®Google Scholar
• PattersonCMMorrisonRLd’SouzaATengXSHappelKIInhaled fluticasone propionate impairs pulmonary clearance of Klebsiella pneumoniae in miceRespir Res2012134022651370
   PubMed Web of Science ®Google Scholar
• ZetterlundALarssonPHMüller-SuurCPalmbergLLarssonKBudesonide but not terbutaline decreases phagocytosis in alveolar macrophagesRespir Med19989221621669616506
   PubMed Web of Science ®Google Scholar
• GratchevAKzhyshkowskaJUtikalJGoerdtSInterleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophagesScand J Immunol2005611101715644118
   PubMed Web of Science ®Google Scholar
• GilesKMRossKRossiAGHotchinNAHaslettCDransfieldIGlucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active RacJ Immunol2001167297698611441106
   PubMed Web of Science ®Google Scholar
• CostaCGermenaGHirschEDissection of the interplay between class I PI3Ks and Rac signaling in phagocytic functionsScientific-World Journal2010101826183920852826
   PubMed Web of Science ®Google Scholar
• ZhangXMoilanenEKankaanrantaHBeclomethasone, budesonide and fluticasone propionate inhibit human neutrophil apoptosisEur J Pharmacol2001431336537111730731
   PubMed Web of Science ®Google Scholar
• GizyckiMJHattotuwaKLBarnesNJefferyPKEffects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissueThorax200257979980312200525
   PubMed Web of Science ®Google Scholar
• Llewellyn-JonesCGHillSLStockleyRAEffect of fluticasone propionate on neutrophil chemotaxis, superoxide generation, and extracellular proteolytic activity in vitroThorax19944932072128202875
   PubMed Web of Science ®Google Scholar
• StrandbergKBlidbergKSahlanderKPalmbergLLarssonKEffect of formoterol and budesonide on chemokine release, chemokine receptor expression and chemotaxis in human neutrophilsPulm Pharmacol Ther201023431632320307681
   PubMed Web of Science ®Google Scholar
• O’LearyECEvansGFZuckermanSHIn vivo dexamethasone effects on neutrophil effector functions in a rat model of acute lung injuryInflammation19972165976089429907
   PubMed Web of Science ®Google Scholar
• BaltchALHammerMCSmithRPComparison of the effect of three adrenal corticosteroids on human granulocyte function against Pseudomonas aeruginosaJ Trauma19862665255333088287
   PubMedGoogle Scholar
• OkitaYMikiCYoshiyamaSNeutrophil dysfunction in steroid-overdosed patients with ulcerative colitis: potential relevance of macrophage migration inhibitory factor to increased postoperative morbiditySurg Today201141111504151121969153
   PubMed Web of Science ®Google Scholar